Retinal Nerve Fiber Layer Thickness in Glaucoma Patients Treated with Multiple Intravitreal Anti-Vegf (Bevacizumab) Injections

Retinal Nerve Fiber Layer Thickness in Glaucoma Patients Treated with Multiple Intravitreal Anti-Vegf (Bevacizumab) Injections

Over the past decade, intravitreal injections of anti-VEGF agents have been widely used and intensively developed as a treatment option for many ophthalmological indications. Due to its availability and low cost, the most frequently used anti-VEGF agent is bevacizumab. This type of therapy is often...

Full description

Bibliographic Details
Main Authors: Andrijana Kopić, Dubravka Biuk, Josip Barać, Maja Vinković, Tvrtka Benašić, Vlatko Kopić
Format: Article
Language:English
Published: Sestre Milosrdnice University hospital, Institute of Clinical Medical Research 2017-01-01
Series:Acta Clinica Croatica
Subjects:
Vascular endothelial growth factor A
Bevacizumab
Retinal degeneration
Macular edema
Diabetes mellitus
Glaucoma, primary open angle
Online Access:https://hrcak.srce.hr/file/282145

Internet

https://hrcak.srce.hr/file/282145

Similar Items